市值超50亿！腾讯投出一个中高端医疗服务IPO

Company Overview - Zhuozheng Medical was listed on the Hong Kong Stock Exchange on February 6, with an initial offering price of HKD 59 per share, opening at HKD 81, a 37.3% increase, and closing at HKD 67.9, a 13.36% increase, with a total market capitalization of HKD 43.72 billion [2] - The IPO involved the issuance of 4.75 million shares, raising a total of HKD 284 million, with a subscription rate of 2730.73 times for the public offering and 5.79 times for the international offering [6] - The company was founded by Wang Zhiyuan and targets the mid-to-high-end medical service market, focusing on affluent individuals with an annual disposable income exceeding RMB 200,000 [6] Industry Insights - The mid-to-high-end private medical service market in China is experiencing rapid growth, with total revenue projected to increase from RMB 193 billion in 2020 to RMB 426.3 billion by 2024, representing a compound annual growth rate (CAGR) of 21.9% [7] - Zhuozheng Medical's revenue for 2022, 2023, and 2024 is projected to be RMB 473 million, RMB 690 million, and RMB 959 million respectively, with profits of RMB -222 million, RMB -353 million, and RMB 80.23 million [7] - The majority of Zhuozheng Medical's revenue comes from physical medical services, accounting for 83.0%, 85.8%, 91.1%, and 92.1% of total revenue for the years 2022, 2023, 2024, and the first eight months of 2025 respectively [7] Financial Performance - The average cost per visit for physical medical services has remained stable, recorded at RMB 1,014, RMB 1,048, RMB 1,195, and RMB 1,185 for the years 2022, 2023, 2024, and the first eight months of 2025 respectively [8] - The company plans to utilize the funds raised from the IPO to develop a talent pool for medical AI applications, upgrade existing medical service institutions, and expand its network of medical service facilities [8]